(Q37910910)

25 August 2017

1 reference

title

Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge (English)

1 reference

25 August 2017

Santiago Montes-Moreno

series ordinal

1

1 reference

25 August 2017

3

1 reference

25 August 2017

2

Carlos Montalbán

1 reference

PubMed ID

21812534

25 August 2017

language of work or name

1 reference

19 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

53

1 reference

25 August 2017

2

1 reference

25 August 2017

185-194

1 reference

Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas

25 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

KSHV- and EBV-associated germinotropic lymphoproliferative disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Molecular histogenesis of plasmablastic lymphoma of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Regulation of plasma-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Germinal centres: role in B-cell physiology and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Expression pattern of XBP1(S) in human B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Blimp-1 Is Required for the Formation of Immunoglobulin Secreting Plasma Cells and Pre-Plasma Memory B Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

ALK-positive diffuse large B-cell lymphoma with the t(2;17)(p23;q23).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Proteasome inhibitors disrupt the unfolded protein response in myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.608447

10.3109/10428194.2011.608447

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21812534